Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $501.1000 (-2.19%) ($499.9000 - $514.8500) on Thu. Jun. 11, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.56% (three month average) | RSI | 8 | Latest Price | $501.1000(-2.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.7% a day on average for past five trading days. | Weekly Trend | REGN declines -10% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(47%) XLV(37%) XBI(36%) QQQ(30%) SPY(29%) | Factors Impacting REGN price | REGN will decline at least -6.28% in a week (0% probabilities). VIXM(-12%) TLT(-6%) SHY(-3%) UUP(-2%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.28% (StdDev 12.56%) | Hourly BBV | 0 () | Intraday Trend | -2.4% | | | |
|
5 Day Moving Average | $520.58(-3.74%) | 10 Day Moving Average | $461.84(8.5%) | 20 Day Moving Average | $483.53(3.63%) | To recent high | -7.1% | To recent low | 18% | Market Cap | $53.131b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |